Skip to main content
. Author manuscript; available in PMC: 2014 Sep 5.
Published in final edited form as: Sci Transl Med. 2014 Mar 5;6(226):226ra32. doi: 10.1126/scitranslmed.3008095

Figure 4. Systemic anti-tumor effect is restricted to the injected tumor type.

Figure 4

(A) Animals were injected i.d. in right flank with B16-F10 melanoma, MC38 colon carcinoma, or PBS, and in the left flank with B16-F10 cells and treated as outlined in the scheme. (B,C) Growth of distant tumors (B) and overall survival (C) of animals that received right B16-F10 or no right flank tumors. Data show representative results from 1 out of 2 independent experiments with 5–10 mice/group. (D,E) Growth of distant tumors (D) and overall survival (E) of animals that received right B16-F10 or MC38 tumors. Data represent results from 1 out of 2 independent experiments with n=10 per group. **p<0.01, ****p<0.0001.